Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy

被引:0
|
作者
Daofu Feng
Meiha Leong
Ting Li
Lin Chen
Tao Li
机构
[1] General Hospital of Chinese PLA,Department of General Surgery
[2] General Hospital of Tianjin Medical University,Department of General Surgery
[3] Kiang Wu Hospital,Department of Surgery
关键词
Gastric cancer; D2 lymphadenectomy; Pathological complete response; Complications; Neoadjuvant chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy
    Feng, Daofu
    Leong, Meiha
    Li, Ting
    Chen, Lin
    Li, Tao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [2] Phase II trial of S-1 combined with oxaliplatin (SOX) as neoadjuvant chemotherapy for locally advanced gastric cancer
    Chen, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [3] Safety and efficacy of neoadjuvant chemotherapy with S-1 and oxaliplatin plus apatinib for locally advanced gastric cancer.
    Zheng, Ya'nan
    Yang, Xiao
    Ni, Zhentian
    Zhu, Zhenglun
    Xu, Wei
    Yang, Zhongyin
    Liu, Wentao
    Yan, Min
    Zhu, Zhenggang
    Li, Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer
    Lee, Duk Joo
    Sohn, Tae Sung
    Lim, Do Hoon
    Ahn, Hee Kyung
    Park, Se Hoon
    Lee, Jeeyun
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Choi, Dong Il
    Kim, Kyoung Mee
    Choi, Min Gew
    Noh, Jae Hyung
    Bae, Jae Moon
    Kim, Sung
    Min, Byung Hoon
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1333 - 1338
  • [5] Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer
    Duk Joo Lee
    Tae Sung Sohn
    Do Hoon Lim
    Hee Kyung Ahn
    Se Hoon Park
    Jeeyun Lee
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Dong Il Choi
    Kyoung Mee Kim
    Min Gew Choi
    Jae Hyung Noh
    Jae Moon Bae
    Sung Kim
    Byung Hoon Min
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1333 - 1338
  • [6] S-1 plus oxaliplatin compared with fluorouracil/leucovorin/oxaliplatin as neoadjuvant chemotherapy for locally advanced gastric carcinoma.
    Yu, Jiren
    Wu, Yijun
    Gao, Yuan
    Shen, Qianyun
    Zhang, Qing
    Liu, Xiaosun
    Zhu, Kankai
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [7] Complete Response of Locally Advanced Gastric Cancer with Pancreatic Invasion and Gastric Outlet Obstruction after Neoadjuvant Chemotherapy with S-1 and Oxaliplatin
    Kondo, Masato
    Nishino, Shogo
    Yamashita, Daisuke
    Kaihara, Satoshi
    CASE REPORTS IN ONCOLOGY, 2020, 13 (02): : 716 - 720
  • [8] Locally advanced gastric cancer treated with neoadjuvant chemotherapy: Epirubicin, oxaliplatin, and capecitabine (EOX)
    Pluschnig, U.
    Zacherl, J.
    Schoppmann, S.
    Raderer, M.
    Prager, G.
    Bartsch, R.
    Ba-Ssalamah, A.
    Lamm, W.
    Zielinski, C.
    Hejna, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [9] Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer
    Takashi Kosaka
    Hirotoshi Akiyama
    Hiroshi Miyamoto
    Sho Sato
    Yusaku Tanaka
    Kei Sato
    Chikara Kunisaki
    Itaru Endo
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 1047 - 1055
  • [10] Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer
    Kosaka, Takashi
    Akiyama, Hirotoshi
    Miyamoto, Hiroshi
    Sato, Sho
    Tanaka, Yusaku
    Sato, Kei
    Kunisaki, Chikara
    Endo, Itaru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (06) : 1047 - 1055